HONG KONG – With a plan to build its own version of the U.S. National Institutes of Health (NIH), Japan is looking to expand the interaction and cooperation between three major ministries and get the most out of the government’s ¥320 billion (US$3 billion) in biological and biomedical research spending.
HONG KONG – China’s biotechnology industry continued to grow rapidly in 2013, expanding by almost 18 percent, according to new numbers from the National Development and Reform Commission (NDRC).
HONG KONG – Vaccine maker Sinovac Biotech Ltd.’s positive results from a phase III clinical trial for its enterovirus 71 (EV71) vaccine for hand, foot and mouth disease (HFMD) are welcome news in China since HFMD has emerged as a health scourge in China.
HONG KONG – Crystalgenomics Inc. released positive phase III clinical trial results for its non-steroidal anti-inflammatory drug (NSAID) polmacoxib for osteoarthritis.
SINGAPORE – Biosimilars are generating more interest among Asian developers, which are rapidly moving into a space that is likely to see skyrocketing sales before the end of the decade.
HONG KONG – A listed Chinese medical diagnostic service provider and a South Korean investment company have launched a new fund to target biopharmaceutical and health care companies.
SINGAPORE – Aware that Asian markets are growing fast and will account for half of global GDP in a few decades, national and multinational biopharmaceutical firms are looking to expand their presence in the region while stepping up their innovative capabilities.
HONG KONG – A Chinese biotechnology company is leading a group of investors, including many of its own top executives, in a joint venture to develop a sought-after drug used to regenerate skin cells in burn victims.
